Akopova II - Search Results

1

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

Zhirnov OP, Isaeva EI, Konakova TE, Thoidis G, Piskareva LM, Akopova II, Kartashov A, Altstein AD, Ilyinskii PO, Shneider AM. Zhirnov OP, et al. Among authors: akopova ii. Influenza Other Respir Viruses. 2007 Mar;1(2):71-9. doi: 10.1111/j.1750-2659.2007.00010.x. Influenza Other Respir Viruses. 2007. PMID: 18784792 Free PMC article.

2

Molecular mechanisms of reversion to the ts+ (non-temperature-sensitive) phenotype of influenza A cold-adapted (ca) virus strains.

Tsfasman TM, Markushin SG, Akopova II, Ghendon YZ. Tsfasman TM, et al. Among authors: akopova ii. J Gen Virol. 2007 Oct;88(Pt 10):2724-2729. doi: 10.1099/vir.0.83014-0. J Gen Virol. 2007. PMID: 17872525

3

Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines.

Ghendon Y, Markushin S, Krivtsov G, Akopova I. Ghendon Y, et al. Arch Virol. 2008;153(5):831-7. doi: 10.1007/s00705-008-0047-4. Epub 2008 Feb 23. Arch Virol. 2008. PMID: 18297235

4

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.

Ghendon YZ, Markushin SG, Akopova II, Koptiaeva IB, Nechaeva EA, Mazurkova LA, Radaeva IF, Kolokoltseva TD. Ghendon YZ, et al. Among authors: akopova ii. Vaccine. 2005 Sep 7;23(38):4678-84. doi: 10.1016/j.vaccine.2005.04.039. Vaccine. 2005. PMID: 16026905

5

[Chitosan as an adjuvant for inactivated vaccines against avian influenza viruses].

Gendon IuZ, Vasil'ev IuM, Markushin SG, Akopova II, Koptiaeva IB, Krivtsov GG. Gendon IuZ, et al. Among authors: akopova ii. Zh Mikrobiol Epidemiol Immunobiol. 2009 Mar-Apr;(2):40-7. Zh Mikrobiol Epidemiol Immunobiol. 2009. PMID: 19459476 Russian.

6

[Chitosan as an adjuvant for parenteral inactivated influenza vaccines].

Gendon IuZ, Markushin SG, Krivtsov GG, Akopova II. Gendon IuZ, et al. Among authors: akopova ii. Vopr Virusol. 2008 Sep-Oct;53(5):14-9. Vopr Virusol. 2008. PMID: 19069787 Russian.

7

Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally.

Ghendon Y, Markushin S, Vasiliev Y, Akopova I, Koptiaeva I, Krivtsov G, Borisova O, Ahmatova N, Kurbatova E, Mazurina S, Gervazieva V. Ghendon Y, et al. J Med Virol. 2009 Mar;81(3):494-506. doi: 10.1002/jmv.21415. J Med Virol. 2009. PMID: 19152418

8

[Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].

Markushin SG, Gendon IuZ, Krivtsov GG, Akopova II, Sukhno AS, Pereverzev AD. Markushin SG, et al. Among authors: akopova ii. Zh Mikrobiol Epidemiol Immunobiol. 2010 Sep-Oct;(5):29-34. Zh Mikrobiol Epidemiol Immunobiol. 2010. PMID: 21061574 Russian.

9

Chitosan as an adjuvant for poliovaccine.

Ghendon Y, Markushin S, Akopova I, Koptiaeva I, Krivtsov G. Ghendon Y, et al. J Med Virol. 2011 May;83(5):847-52. doi: 10.1002/jmv.22030. J Med Virol. 2011. PMID: 21412793

10

[Enhancing the immunogenicity of inactivated polio vaccines with chitosan used as an adjuvant].

Gendon IuZ, Markushin SG, Akopova II, Krivtsov GG, Akhmatova NK, Koptiaeva IB, Vasil'ev IuM. Gendon IuZ, et al. Among authors: akopova ii. Vopr Virusol. 2011 Nov-Dec;56(6):28-32. Vopr Virusol. 2011. PMID: 22359946 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters